ResearchAndMarkets.com released a comprehensive report analyzing over 1,230 bioinformatics collaboration and licensing deals from 2019 to 2026. The report offers detailed insights into deal structures, including upfront payments, milestones, royalties, and contract terms, helping companies benchmark transactions and negotiate partnerships effectively. It highlights how data, algorithms, and technology platforms drive dealmaking in bioinformatics, providing transparency on rights, responsibilities, and financial arrangements. This resource supports strategic decision-making and valuation in a data-driven biotech market.
Torex Gold Resources reported Q2 2026 production of 96,297 gold equivalent ounces, meeting expectations despite mining lower-grade areas. The company generated $94 million in free cash flow and returned $55 million to shareholders during the quarter....
10x Genomics reported Q2 2026 revenue of $151 million, up 3% from last year excluding patent settlement income. The company acquired Proteintech Genomics to enhance its multiomics capabilities and announced collaborations to advance cancer diagnostic...
